日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

(89)Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer.

(89)Zr标记的nivolumab用于人源化小鼠肺癌模型中T细胞浸润的成像

England Christopher G, Jiang Dawei, Ehlerding Emily B, Rekoske Brian T, Ellison Paul A, Hernandez Reinier, Barnhart Todd E, McNeel Douglas G, Huang Peng, Cai Weibo

Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab.

89Zr标记的帕博利珠单抗的临床前药代动力学和生物分布研究

England Christopher G, Ehlerding Emily B, Hernandez Reinier, Rekoske Brian T, Graves Stephen A, Sun Haiyan, Liu Glenn, McNeel Douglas G, Barnhart Todd E, Cai Weibo

Immunotherapy for prostate cancer: False promises or true hope?

前列腺癌免疫疗法:虚假的承诺还是真正的希望?

Rekoske, Brian T; McNeel, Douglas G